| SANGAMO THERAP.INC.DL-,01 |
| USA |
| Gesundheit |
| US8006771062 / 936386 |
| GBY (Frankfurt) / SGMO (NASDAQ) |
| FRA:GBY, ETR:GBY, GBY:GR, NASDAQ:SGMO |
| - |
| https://www.sangamo.com/ |
|
Sangamo Therapeutics Inc. is a biotechnology compa..
>Volltext.. |
| 126.49 Mio. EUR |
| 122.14 Mio. EUR |
| 28.02 Mio. EUR |
| -87.34 Mio. EUR |
| -92.83 Mio. EUR |
| -0.38 EUR |
| 21.67 Mio. EUR |
| 26.02 Mio. EUR |
| -64.91 Mio. EUR |
| 0.61 |
| -40.35% |
| 24.09% |
| - |
| - |
| - |
| - |
| SANGAMO |
| 17.12.25 |
|